PNA Synthesis Service

A peptide nucleic acid, or PNA, is a synthetic nucleic-acid analog whose bases are attached to an uncharged peptide-like backbone instead of the sugar-phosphate chain found in DNA and RNA. First reported in the 1980s, it is often described as a third-generation antisense agent. Because the backbone carries no charge, a PNA strand does not repel the negatively charged phosphate backbone of a target nucleic acid, so its pairing with DNA or RNA is both more stable and more specific than the natural interaction. PNA is also resistant to the nucleases and proteases that degrade normal nucleic acids and peptides, which makes it unusually stable in both cellular and cell-free environments. A custom PNA synthesis service produces these molecules to order, with or without labels, and supports the project from sequence design through a characterized final product.

Figure 1. PNAs hybridize to complementary DNAFigure 1. PNAs hybridize to complementary DNA by hydrogen bonding. (Source: Wu JC, et al. 2017)

How PNA Interacts with Nucleic Acids

The uncharged, high-affinity nature of PNA gives it several binding modes that are difficult for ordinary oligos to achieve, and which are what make it useful as a research and diagnostic tool.

  • Strand invasion. A purine-rich PNA can displace one strand of a double helix and insert itself, creating a PNA-DNA duplex against the target strand.
  • Double duplex invasion. Under the right conditions a PNA can invade a duplex together with a second PNA, forming a stable complex that opens the target — a route that works best when the invading PNA carries modified bases.
  • Triple-helix formation. A cytosine-rich PNA binds in the major groove of a complementary duplex to form a PNA-DNA triplex, useful for recognition of specific sites without full strand displacement.
  • PNA-DNA-PNA complexes. Two PNA strands can bind opposite faces of a target, giving a particularly stable triplex held between them. Because PNA-PNA pairing is stronger than PNA-DNA pairing, the design must avoid sequences that would make the probe bind itself.

Applications

PNA is used wherever a probe or inhibitor must bind DNA or RNA with high stability and specificity. Common uses include antisense and gene-expression studies, the detection and capture of specific sequences in diagnostics, sequence-specific molecular tools such as biosensors, antimicrobial and anti-pest research, and any assay that benefits from a nuclease-resistant, high-affinity capture strand.

Service Options

The same synthesis platform supports both plain and modified molecules, and the choice is made on what the experiment needs.

Unlabeled PNA synthesis. Plain PNA is synthesized to the requested length and quantity, purified, and delivered with the characterization needed to confirm identity and purity. This is the right choice when the molecule is used internally or captured indirectly.

Labeled and modified PNA synthesis. A broad set of fluorescent and quencher dyes can be attached for direct detection, and a range of functional groups is available — amines, thiols, azides, acetylated and maleimide ends, and biotin for affinity capture — together with linker spacers and backbone modifications such as gamma and alpha variants that improve solubility and binding. The label and modification are selected to match the readout and conjugation chemistry of the assay.

Sequence Design Guidance

Good results depend on a design that the molecule can actually form, and several practical rules are applied during the design check.

  • Length. Practical synthesis lengths are kept short, typically around eighteen bases or fewer, not counting any linker, amino acid, or label that is added at the ends.
  • Purine balance. Runs of purines, and guanine in particular, make a PNA prone to aggregation and poorly soluble; sequences are kept below about four consecutive purines and about three consecutive guanines, with total purine content held below roughly three fifths of the sequence where possible.
  • Avoiding self-binding. Because PNA pairs with itself more strongly than with DNA, reverse repeats, hairpins, and palindromes are avoided; strongly self-complementary stretches are reviewed and, where necessary, redesigned before synthesis.
  • Terminal amino acids. A lysine or cysteine can be added at the N or C terminus when the application needs an extra handle for conjugation or capture.

How an Order Runs

A project begins when the customer supplies the target sequence and the requirements — length, quantity, purity, and any label or modification. The design is reviewed against the rules above, and where a sequence is likely to misbehave the issue is raised before any synthesis is committed. The molecule is then synthesized and purified, checked by purity analysis and mass spectrometry, and delivered with a report covering both. Scales run from the low nanomole range up to milligram amounts, and typical turnaround is a few weeks depending on length, modification, and quantity.

Reference

  1. Wu JC, et al. Recent advances in peptide nucleic acid for cancer bionanotechnology. Acta Pharmacol Sin. 2017 Jun;38(6):798-805.
The service is for research only, not for clinical use.
0
Inquiry Basket